https://www.acumenresearchandconsulting.com/
Home Services Industry Services Press Releases About Us Blogs Report Store Contact us

Controlled Release Drug Delivery Market Analysis - Global Industry Size, Share, Trends and Forecast 2022 - 2030

Published : Jul 2022

Report ID: ARC981

Pages : 160

Format : Controlled Release Drug Delivery Market Analysis - Global Industry Size, Share, Trends and Forecast 2022 - 2030

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
       1.1.1. Definition of Controlled Release Drug Delivery
       1.1.2. Market Segmentation
       1.1.3. List of Abbreviations
1.2. Summary
       1.2.1. Market Snapshot
       1.2.2. Controlled Release Drug Delivery Market By Release Mechanism
                 1.2.2.1. Global Controlled Release Drug Delivery Market Revenue and Growth Rate Comparison By Release Mechanism (2015-2026)
                 1.2.2.2. Global Controlled Release Drug Delivery Market Revenue Share By Release Mechanism in 2017
                 1.2.2.3. Polymer Based Systems
                 1.2.2.4. Micro Reservoir Partition Controlled Drug Delivery Systems
                 1.2.2.5. Feedback Regulated Drug Delivery Systems
                 1.2.2.6. Activation-modulated Drug Delivery Systems
                 1.2.2.7. Chemically Activated
                 1.2.2.8. Others
       1.2.3. Controlled Release Drug Delivery Market By Technology
                 1.2.3.1. Global Controlled Release Drug Delivery Market Revenue and Growth Rate Comparison By Technology (2015-2026)
                 1.2.3.2. Wurster Technique
                 1.2.3.3. Coacervation
                 1.2.3.4. Micro Encapsulation
                 1.2.3.5. Implants
                 1.2.3.6. Transdermal
                 1.2.3.7. Targeted Delivery
                 1.2.3.8. Others
       1.2.4. Controlled Release Drug Delivery Market By Application
                 1.2.4.1. Global Controlled Release Drug Delivery Market Revenue and Growth Rate Comparison By Application (2015-2026)
                 1.2.4.2. Metered Dose Inhalers
                 1.2.4.3. Injectable
                 1.2.4.4. Transdermal and Ocular Patches
                 1.2.4.5. Infusion Pumps
                 1.2.4.6. Oral Controlled-drug delivery Systems
                 1.2.4.7. Drug Eluting Stents
                 1.2.4.8. Others
       1.2.5. Controlled Release Drug Delivery Market by Geography
                 1.2.5.1. Global Controlled Release Drug Delivery Market Revenue and Growth Rate Comparison by Geography (2015-2026)
                 1.2.5.2. North America Controlled Release Drug Delivery Market Revenue and Growth Rate (2015-2026)
                 1.2.5.3. Europe Controlled Release Drug Delivery Market Revenue and Growth Rate (2015-2026)
                 1.2.5.4. Asia-Pacific Controlled Release Drug Delivery Market Revenue and Growth Rate (2015-2026)
                 1.2.5.5. Latin America Controlled Release Drug Delivery Market Revenue and Growth Rate (2015-2026)
                 1.2.5.6. Middle East and Africa (MEA) Controlled Release Drug Delivery Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
       2.4.1. Bargaining Power of Suppliers
       2.4.2. Bargaining Power of Buyers
       2.4.3. Threat of Substitute
       2.4.4. Threat of New Entrants
       2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
       2.6.1. Raw Material and Suppliers
       2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
       2.8.1. Player Positioning Analysis
       2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Controlled Release Drug Delivery Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Controlled Release Drug Delivery Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Controlled Release Drug Delivery Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Controlled Release Drug Delivery Major Manufacturers in 2017

CHAPTER 4. CONTROLLED RELEASE DRUG DELIVERY MARKET BY RELEASE MECHANISM

4.1. Global Controlled Release Drug Delivery Revenue By Release Mechanism
4.2. Polymer Based Systems
       4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Micro Reservoir Partition Controlled Drug Delivery Systems
       4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Feedback Regulated Drug Delivery Systems
       4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Activation-modulated Drug Delivery Systems
       4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Chemically Activated
       4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.7. Other
       4.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       4.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. CONTROLLED RELEASE DRUG DELIVERY MARKET BY TECHNOLOGY

5.1. Global Controlled Release Drug Delivery Revenue By Technology
5.2. Wurster Technique
       5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Coacervation
       5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Micro Encapsulation
       5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Implants
       5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Transdermal
       5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.7. Targeted Delivery
       5.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.8. Others
       5.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       5.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. CONTROLLED RELEASE DRUG DELIVERY MARKET BY APPLICATION

6.1. Global Controlled Release Drug Delivery Revenue By Application
6.2. Metered Dose Inhalers
       6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Injectable
       6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Transdermal and Ocular Patches
       6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Infusion Pumps
       6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.6. Oral Controlled-drug delivery Systems
       6.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.7. Drug Eluting Stents
       6.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.8. Others
       6.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
       6.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA CONTROLLED RELEASE DRUG DELIVERY MARKET BY COUNTRY

7.1. North America Controlled Release Drug Delivery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Controlled Release Drug Delivery Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
       7.3.1. U.S. Controlled Release Drug Delivery Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
       7.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       7.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4. Canada
       7.4.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
       7.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       7.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5. Mexico
       7.5.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
       7.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       7.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE CONTROLLED RELEASE DRUG DELIVERY MARKET BY COUNTRY

8.1. Europe Controlled Release Drug Delivery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Controlled Release Drug Delivery Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
       8.3.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
       8.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       8.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4. Germany
       8.4.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
       8.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       8.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5. France
       8.5.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
       8.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       8.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.6. Spain
       8.6.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
       8.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       8.6.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.7. Rest of Europe
       8.7.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
       8.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       8.7.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET BY COUNTRY

9.1. Asia-Pacific Controlled Release Drug Delivery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Controlled Release Drug Delivery Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
       9.3.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
       9.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       9.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4. Japan
       9.4.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
       9.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       9.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5. India
       9.5.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
       9.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       9.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.6. Australia
       9.6.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
       9.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       9.6.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.7. South Korea
       9.7.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
       9.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       9.7.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
       9.8.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
       9.8.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
       9.8.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA CONTROLLED RELEASE DRUG DELIVERY MARKET BY COUNTRY

10.1. Latin America Controlled Release Drug Delivery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Controlled Release Drug Delivery Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
        10.3.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
        10.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
        10.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4. Argentina
        10.4.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
        10.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
        10.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5. Rest of Latin America
        10.5.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
        10.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
        10.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST CONTROLLED RELEASE DRUG DELIVERY MARKET BY COUNTRY

11.1. Middle East Controlled Release Drug Delivery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Controlled Release Drug Delivery Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
        11.3.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
        11.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
        11.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4. UAE
        11.4.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
        11.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
        11.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5. Rest of Middle East
        11.5.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
        11.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
        11.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET BY COUNTRY

12.1. Africa Controlled Release Drug Delivery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Controlled Release Drug Delivery Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
        12.3.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
        12.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
        12.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.4. Egypt
        12.4.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
        12.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
        12.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.5. Rest of Africa
        12.5.1. Market Revenue and Forecast By Release Mechanism, 2015 - 2026 ($Million)
        12.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
        12.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Capsugel
        13.1.1. Company Snapshot
        13.1.2. Overview
        13.1.3. Financial Overview
        13.1.4. Type Portfolio
        13.1.5. Key Developments
        13.1.6. Strategies
13.2. Orbis Biosciences, Inc.
        13.2.1. Company Snapshot
        13.2.2. Overview
        13.2.3. Financial Overview
        13.2.4. Type Portfolio
        13.2.5. Key Developments
        13.2.6. Strategies
13.3. Pfizer, Inc
        13.3.1. Company Snapshot
        13.3.2. Overview
        13.3.3. Financial Overview
        13.3.4. Type Portfolio
        13.3.5. Key Developments
        13.3.6. Strategies
13.4. Merck and Co., Inc.
        13.4.1. Company Snapshot
        13.4.2. Overview
        13.4.3. Financial Overview
        13.4.4. Type Portfolio
        13.4.5. Key Developments
        13.4.6. Strategies
13.5. Johnson and Johnson
        13.5.1. Company Snapshot
        13.5.2. Overview
        13.5.3. Financial Overview
        13.5.4. Type Portfolio
        13.5.5. Key Developments
        13.5.6. Strategies
13.6. Alkermes plc
        13.6.1. Company Snapshot
        13.6.2. Overview
        13.6.3. Financial Overview
        13.6.4. Type Portfolio
        13.6.5. Key Developments
        13.6.6. Strategies
13.7. Coating Place, Inc.
        13.7.1. Company Snapshot
        13.7.2. Overview
        13.7.3. Financial Overview
        13.7.4. Type Portfolio
        13.7.5. Key Developments
        13.7.6. Strategies
13.8. Depomed, Inc.
        13.8.1. Company Snapshot
        13.8.2. Overview
        13.8.3. Financial Overview
        13.8.4. Type Portfolio
        13.8.5. Key Developments
        13.8.6. Strategies
13.9. Corium International, Inc.
        13.9.1. Company Snapshot
        13.9.2. Overview
        13.9.3. Financial Overview
        13.9.4. Type Portfolio
        13.9.5. Key Developments
        13.9.6. Strategies
13.10. Aradigm Corporation
          13.10.1. Company Snapshot
          13.10.2. Overview
          13.10.3. Financial Overview
          13.10.4. Type Portfolio
          13.10.5. Key Developments
          13.10.6. Strategies
13.11. Others
          13.11.1. Company Snapshot
          13.11.2. Overview
          13.11.3. Financial Overview
          13.11.4. Type Portfolio
          13.11.5. Key Developments
          13.11.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
          14.1.1. Initial Data Search
          14.1.2. Secondary Research
          14.1.3. Primary Research
14.2. Assumptions and Scope

Frequently Asked Questions

Select Licence Type

Single User

US$ 4500

Multi User

US$ 7000

Excel Datapack

US$ 2000

Why Acumen Research And Consulting

100%

Customer Satisfaction

24x7

Availability - we are always there when you need us

200+

Fortune 50 Companies trust Acumen Research and Consulting

80%

of our reports are exclusive and first in the industry

100%

more data and analysis

1000+

reports published till date